Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Instillations of LE Ophthalmic Gel
Phase of Trial: Phase I
Latest Information Update: 14 May 2019
Price : $35 *
At a glance
- Drugs Loteprednol etabonate (Primary)
- Indications Allergic conjunctivitis; Keratoconjunctivitis sicca; Ocular inflammation; Ocular pain
- Focus Pharmacokinetics
- Sponsors Bausch & Lomb
- 16 May 2017 Status changed from recruiting to completed.
- 25 Apr 2017 Status changed from not yet recruiting to recruiting.
- 07 Apr 2017 New trial record